ES2245028T3 - Uso de lactoferrina en el tratamiento de trastornos inducidos por alergenos. - Google Patents

Uso de lactoferrina en el tratamiento de trastornos inducidos por alergenos.

Info

Publication number
ES2245028T3
ES2245028T3 ES98915471T ES98915471T ES2245028T3 ES 2245028 T3 ES2245028 T3 ES 2245028T3 ES 98915471 T ES98915471 T ES 98915471T ES 98915471 T ES98915471 T ES 98915471T ES 2245028 T3 ES2245028 T3 ES 2245028T3
Authority
ES
Spain
Prior art keywords
lactoferrin
tnf
induced
treatment
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98915471T
Other languages
English (en)
Spanish (es)
Inventor
Ian Kimber
Marie Cumberbatch
Rebecca J. Dearman
Orla M. Conneely
Pauline Ward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agennix Inc
Original Assignee
Agennix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agennix Inc filed Critical Agennix Inc
Application granted granted Critical
Publication of ES2245028T3 publication Critical patent/ES2245028T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES98915471T 1997-04-10 1998-04-10 Uso de lactoferrina en el tratamiento de trastornos inducidos por alergenos. Expired - Lifetime ES2245028T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4189097P 1997-04-10 1997-04-10
US41890P 1997-04-10

Publications (1)

Publication Number Publication Date
ES2245028T3 true ES2245028T3 (es) 2005-12-16

Family

ID=21918897

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98915471T Expired - Lifetime ES2245028T3 (es) 1997-04-10 1998-04-10 Uso de lactoferrina en el tratamiento de trastornos inducidos por alergenos.

Country Status (12)

Country Link
US (1) US20030190303A1 (https=)
EP (1) EP0979099B1 (https=)
JP (1) JP2001519815A (https=)
CN (1) CN1262625A (https=)
AT (1) ATE297755T1 (https=)
AU (1) AU747385C (https=)
CA (1) CA2285960A1 (https=)
DE (1) DE69830582T2 (https=)
ES (1) ES2245028T3 (https=)
IL (1) IL132293A0 (https=)
NZ (1) NZ500712A (https=)
WO (1) WO1998044940A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0980261A4 (en) * 1997-05-03 2003-04-23 Univ Texas METHOD FOR PREVENTING AND TREATING A METABOLIC INBALANCE Caused By Insulin In Humans And Other Animals
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
AU782539B2 (en) * 2000-01-14 2005-08-04 Meiji Dairies Corporation Antigen-specific IgE antibody production inhibitors
RU2165769C1 (ru) * 2000-07-13 2001-04-27 Якубовская Раиса Ивановна Антибактериальный, антиоксидантный, иммуномодулирующий и антиканцерогенный препарат и способ его применения
EP2295081B1 (en) 2001-06-26 2018-10-31 Amgen Inc. Antibodies to OPGL
JP3668241B2 (ja) * 2001-12-28 2005-07-06 株式会社Ｎｒｌファーマ 脂質代謝改善用組成物
WO2003061688A1 (en) * 2002-01-21 2003-07-31 Nrl Pharma, Inc. Novel analgesics
AU2003239393A1 (en) 2002-05-10 2003-11-11 Agennix Incorporated Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
AU2003233583A1 (en) 2002-05-24 2003-12-12 Agennix Incorporated Oral lactoferrin in the treatment of respiratory disorders
KR101317045B1 (ko) 2002-09-06 2013-10-16 암젠 인코포레이티드 치료학적 인체 항-ｉｌ-1ｒ1 모노클로날 항체
EP2298338B1 (en) * 2002-09-16 2012-08-22 Agennix Incorporated Lactoferrin compositions and methods of treatment of skin wounds
WO2004052281A2 (en) * 2002-12-06 2004-06-24 Agennix Incorporated Oral lactoferrin in the treatment of sepsis
WO2004052305A2 (en) 2002-12-10 2004-06-24 Agennix Incorporated Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
WO2005046571A2 (en) * 2003-06-06 2005-05-26 Agennix Incorporated Lactoferrin as an adjuvant in cancer vaccines
US20050075277A1 (en) * 2003-07-10 2005-04-07 Agennix Incorporated Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects
WO2005121329A2 (en) * 2004-06-11 2005-12-22 Syngenta Limited Method for ameliorating an inflammatory skin condition
WO2006047744A2 (en) 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
DK1833495T3 (da) * 2005-03-15 2008-06-02 Campina Nederland Holding Bv Dermatologisk anvendelse af mælkeproteiner
US8178486B2 (en) * 2005-07-21 2012-05-15 Animal Technology Institute Taiwan Method for promoting hair growth
EP1937298A4 (en) * 2005-10-14 2009-11-11 Auckland Uniservices Ltd USE OF LACTOFERRIN FRAGMENTS AND HYDROLYSATES
JPWO2007049757A1 (ja) * 2005-10-27 2009-04-30 サンスター株式会社 ラクトフェリンを含んだリポソームを含有する破骨細胞増加抑制剤、経口組成物及び骨疾患の予防又は治療剤
CN105412912A (zh) * 2010-04-23 2016-03-23 普若拜特有限公司 湿疹治疗
CN102370964B (zh) * 2010-08-16 2015-12-09 李兴德 白细胞介素受体拮抗蛋白在制备皮肤外用制剂中的应用
IT201800002457A1 (it) * 2018-02-07 2019-08-07 Neilos S R L Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie
US12403181B2 (en) 2018-08-13 2025-09-02 Iltoo Pharma Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof
CN114867368A (zh) * 2019-12-11 2022-08-05 N·V·努特里奇亚 用于提高免疫适宜的营养组合物
WO2023222565A1 (en) 2022-05-16 2023-11-23 Institut National de la Santé et de la Recherche Médicale Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation
CN115737787B (zh) * 2022-12-15 2024-04-19 四川大学 乳铁蛋白联合胆碱在制备预防和/或治疗阿尔兹海默症的药物中的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2596986B1 (fr) * 1986-04-11 1988-09-23 Sederma Sa Utilisation de la lactoferrine dans des preparations cosmetiques, antiradicaux libres
FR2641696B2 (fr) * 1986-04-11 1991-03-08 Sederma Sa Utilisation d'un melange renfermant de la lactoferrine dans des preparations cosmetiques anti-radicaux libres
FR2685202B1 (fr) * 1991-12-24 1995-03-24 Sederma Sa Nouvelle methode de traitement pharmaceutique et cosmetique pour la regulation de la seborrhee, de l'acne et de la flore cutanee.
JP3184923B2 (ja) * 1992-01-08 2001-07-09 ビオ セレ ラボラトワール エス ア 抗リウマチ剤
JPH05279266A (ja) * 1992-04-02 1993-10-26 Imuno Japan:Kk 歯周病の治療・予防用医薬組成物
JP3163171B2 (ja) * 1992-07-15 2001-05-08 森永乳業株式会社 ＩｇＡ産生促進剤
JP3746081B2 (ja) * 1994-02-24 2006-02-15 森永乳業株式会社 動物皮膚病治療剤
JPH0859450A (ja) * 1994-08-18 1996-03-05 Kose Corp 皮膚外用剤
JP2832517B2 (ja) * 1994-12-09 1998-12-09 雪印乳業株式会社 大腸菌付着阻止剤
JP3911642B2 (ja) * 1995-06-06 2007-05-09 株式会社加美乃素本舗 皮膚外用剤
JP3888707B2 (ja) * 1996-01-22 2007-03-07 森永乳業株式会社 血管新生病治療剤
US6111081A (en) * 1996-05-31 2000-08-29 Baylor College Of Medicine Lactoferrin variants and uses thereof

Also Published As

Publication number Publication date
AU6964798A (en) 1998-10-30
ATE297755T1 (de) 2005-07-15
DE69830582D1 (de) 2005-07-21
IL132293A0 (en) 2001-03-19
CA2285960A1 (en) 1998-10-15
CN1262625A (zh) 2000-08-09
AU747385B2 (en) 2002-05-16
AU747385C (en) 2003-01-30
EP0979099A1 (en) 2000-02-16
WO1998044940A1 (en) 1998-10-15
JP2001519815A (ja) 2001-10-23
US20030190303A1 (en) 2003-10-09
DE69830582T2 (de) 2006-05-04
NZ500712A (en) 2002-10-25
EP0979099B1 (en) 2005-06-15

Similar Documents

Publication Publication Date Title
ES2245028T3 (es) Uso de lactoferrina en el tratamiento de trastornos inducidos por alergenos.
EA028343B1 (ru) Лечение дегенеративного заболевания сустава
AU2014244744A1 (en) Pharmaceutical composition for inhibiting immune response through inducing differentiation into regulator T cells and promoting proliferation of regulator T cells
WO2016093326A1 (ja) 血管新生病の免疫療法
AU2023233094B2 (en) Anti-inflammatory agents
JP2001511797A (ja) 創傷の治癒
Quagliata et al. Therapeutic applications of thymosin peptides: a patent landscape 2018-present
EA010650B1 (ru) Защищающие ткань цитокины для лечения и профилактики сепсиса и образования спаек
JP4129994B2 (ja) 組織因子凝固系インヒビター含有血管新生阻害剤
CN118421606A (zh) Bace1多肽及其应用
US20180147262A1 (en) Novel skin medical and cosmetic care product
JP6934051B2 (ja) 皮膚炎症抑制用ペプチドおよびそれを含む皮膚炎症の予防または治療用組成物
KR101994595B1 (ko) 섬망 예방용 또는 치료용 약학 조성물
JP2001151695A (ja) アレルギー疾患処置剤
AU2003200309B2 (en) Pharmaceutical Composition for Preventing or Treating Ischaemic Diseases
US6348488B1 (en) Remedies for motor dysfunction and GAPDH expression inhibitors
JP2000086533A (ja) 新規なアレルギー治療剤
EP4415745A1 (en) Collagen 7 protein replacement therapy
MXPA99009240A (en) Use of lactoferin in the treatment of allergen induced disorders
JPH0827026A (ja) 肝疾患の予防・治療薬
JPH01172344A (ja) エンケファリナーゼ含有医薬製剤
HK1247102B (zh) 用於治疗衰老相关病症的方法和组合物
JPH09165343A (ja) 医薬組成物